Trial intelligence / Profile preview

FSME-IMMUN Junior vaccination in children after thymectomy

2004-002647-27Phase 4Completed

Sponsor
Universitätsklinik für Kinder- und Jugendheilkunde
Start
Feb 2005
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, open-label trial of tick-borne encephalitis vaccine (inactivated) in tick-borne encephalitis (TBE) (2 arms), sponsored by Universitätsklinik für Kinder- und Jugendheilkunde. Primary endpoint: FSME-antibody titers at baseline. Started Feb 2005; status: completed.

02

Drugs

tick-borne encephalitis vaccine (inactivated)
03

Conditions

tick-borne encephalitis (TBE)

Beyond the preview

Go deeper on 2004-002647-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002647-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call